;PMID: 11850541
;source_file_609.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..33] = [t:0..33]
;1)sentence:[e:38..170] = [t:38..170]
;2)section:[e:174..266] = [t:174..266]
;3)section:[e:270..376] = [t:270..376]
;4)sentence:[e:380..481] = [t:380..481]
;5)sentence:[e:482..590] = [t:482..590]
;6)sentence:[e:591..729] = [t:591..729]
;7)sentence:[e:730..896] = [t:730..896]
;8)sentence:[e:897..962] = [t:897..962]
;9)sentence:[e:963..1019] = [t:963..1019]
;10)sentence:[e:1020..1090] = [t:1020..1090]
;11)sentence:[e:1091..1303] = [t:1091..1303]
;12)sentence:[e:1304..1537] = [t:1304..1537]
;13)sentence:[e:1538..1684] = [t:1538..1684]
;14)sentence:[e:1685..1813] = [t:1685..1813]
;15)sentence:[e:1814..1983] = [t:1814..1983]
;16)section:[e:1984..2080] = [t:1984..2080]
;17)section:[e:2084..2129] = [t:2084..2129]

;section 0 Span:0..33
;Mod Pathol  2002 Feb;15(2):125-36
(SEC
  (FRAG (NNP:[0..3] Mod) (NNP:[4..10] Pathol) (VBD:[12..16] 2002)
        (DT:[17..22] Feb;1) (CD:[22..23] 5) (NN:[23..24] -LRB-) (CD:[24..25] 2)
        (NN:[25..26] -RRB-) (::[26..27] :) (CD:[27..29] 12) (CD:[29..33] 5-36)))

;sentence 1 Span:38..170
;c-kit mutations in gastrointestinal stromal tumors occur preferentially in
;the  spindle rather than in the epithelioid cell variant.
;[38..43]:gene-rna:"c-kit"
;[57..88]:malignancy:"gastrointestinal stromal tumors"
(SENT
  (S-HLN
    (NP-SBJ
      (NP (NN:[38..43] c-kit) (NNS:[44..53] mutations))
      (PP-LOC (IN:[54..56] in)
        (NP (JJ:[57..73] gastrointestinal) (JJ:[74..81] stromal)
            (NNS:[82..88] tumors))))
    (VP (VBP:[89..94] occur)
      (PP-LOC
        (ADVP (RB:[95..109] preferentially))
        (IN:[110..112] in)
        (NP (DT:[113..116] the) (NN:[118..125] spindle)))
      (PP (IN:[126..132] rather) (IN:[133..137] than)
        (PP-LOC (IN:[138..140] in)
          (NP (DT:[141..144] the) (JJ:[145..156] epithelioid)
              (NN:[157..161] cell) (NN:[162..169] variant)))))
    (.:[169..170] .)))

;section 2 Span:174..266
;Wardelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer HP, Pfeifer
;U,  Pietsch T.
(SEC
  (FRAG (NNP:[174..184] Wardelmann) (NNP:[185..186] E) (,:[186..187] ,)
        (NNP:[188..193] Neidt) (NNP:[194..195] I) (,:[195..196] ,)
        (NNP:[197..205] Bierhoff) (NNP:[206..207] E) (,:[207..208] ,)
        (NNP:[209..216] Speidel) (NNP:[217..218] N) (,:[218..219] ,)
        (NNP:[220..228] Manegold) (NNP:[229..231] C,) (NNP:[232..239] Fischer)
        (NNP:[240..242] HP) (,:[242..243] ,) (NNP:[244..251] Pfeifer)
        (NNP:[252..253] U) (,:[253..254] ,) (NNP:[256..263] Pietsch)
        (NNP:[264..266] T.)))

;section 3 Span:270..376
;Department of Pathology, University of Bonn Medical Center, Bonn, Germany. 
;eva.wardelmann@ukb.uni-bonn.de
(SEC
  (FRAG (NNP:[270..280] Department) (IN:[281..283] of)
        (NNP:[284..293] Pathology) (,:[293..294] ,) (NNP:[295..305] University)
        (IN:[306..308] of) (NNP:[309..313] Bonn) (NNP:[314..321] Medical)
        (NNP:[322..328] Center) (,:[328..329] ,) (NNP:[330..334] Bonn)
        (,:[334..335] ,) (NNP:[336..343] Germany) (.:[343..344] .)
        (``:[346..367] eva.wardelmann@ukb.un) (JJ:[367..376] i-bonn.de)))

;sentence 4 Span:380..481
;Gastrointestinal stromal tumors (GISTs) coexpress CD34 and the Kit 
;tyrosine-kinase receptor (CD117).
;[380..411]:malignancy:"Gastrointestinal stromal tumors"
;[413..418]:malignancy:"GISTs"
;[430..434]:gene-protein:"CD34"
;[443..472]:gene-protein:"Kit  tyrosine-kinase receptor"
;[474..479]:gene-protein:"CD117"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[380..396] Gastrointestinal) (JJ:[397..404] stromal)
          (NNS:[405..411] tumors))
      (NP (-LRB-:[412..413] -LRB-) (NNS:[413..418] GISTs)
          (-RRB-:[418..419] -RRB-)))
    (VP (VBP:[420..429] coexpress)
      (NP
        (NP (NN:[430..434] CD34))
        (CC:[435..438] and)
        (NP
          (NP (DT:[439..442] the)
             (NN:[443..446] Kit)
            (NML (NN:[448..456] tyrosine) (HYPH:[456..457] -)
                 (NN:[457..463] kinase))
            (NN:[464..472] receptor))
          (NP (-LRB-:[473..474] -LRB-) (NN:[474..479] CD117)
              (-RRB-:[479..480] -RRB-)))))
    (.:[480..481] .)))

;sentence 5 Span:482..590
;A subset of GISTs carry gain-of-function  mutations of the c-kit
;proto-oncogene in its juxtamembrane domain.
;[494..499]:malignancy:"GISTs"
;[506..522]:variation-type:"gain-of-function"
;[524..533]:variation-event:"mutations"
;[541..546]:gene-rna:"c-kit"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[482..483] A) (NN:[484..490] subset))
      (PP (IN:[491..493] of)
        (NP (NNS:[494..499] GISTs))))
    (VP (VBP:[500..505] carry)
      (NP
        (NP
          (NML
            (NML (NN:[506..510] gain))
            (HYPH:[510..511] -)
            (PP (IN:[511..513] of) (HYPH:[513..514] -)
              (NP (NN:[514..522] function))))
          (NNS:[524..533] mutations))
        (PP (IN:[534..536] of)
          (NP
            (NP (DT:[537..540] the) (NN:[541..546] c-kit) (AFX:[547..552] proto)
                (HYPH:[552..553] -) (NN:[553..561] oncogene))
            (PP-LOC (IN:[562..564] in)
              (NP (PRP$:[565..568] its) (NN:[569..582] juxtamembrane)
                  (NN:[583..589] domain)))))))
    (.:[589..590] .)))

;sentence 6 Span:591..729
;The  relationship between the mutational status and histological as well as 
;immunohistochemical features has not been assessed in detail.
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[591..594] The) (NN:[596..608] relationship))
      (PP (IN:[609..616] between)
        (NP
          (NP (DT:[617..620] the) (JJ:[621..631] mutational)
              (NN:[632..638] status))
          (CC:[639..642] and)
          (NP
            (NP (JJ:[643..655] histological)
              (NML-1 (-NONE-:[655..655] *P*)))
            (CONJP (RB:[656..658] as) (RB:[659..663] well) (IN:[664..666] as))
            (NP (JJ:[668..687] immunohistochemical)
              (NML-1 (NNS:[688..696] features)))))))
    (VP (VBZ:[697..700] has) (RB:[701..704] not)
      (VP (VBN:[705..709] been)
        (VP (VBN:[710..718] assessed)
          (NP-2 (-NONE-:[718..718] *))
          (PP (IN:[719..721] in)
            (NP (NN:[722..728] detail))))))
    (.:[728..729] .)))

;sentence 7 Span:730..896
;36 GISTs and 14  other gastrointestinal mesenchymal tumors were investigated
;for their morphology  and immunophenotype as well as for the presence of
;c-kit mutations.
;[733..738]:malignancy:"GISTs"
;[753..788]:malignancy:"gastrointestinal mesenchymal tumors"
;[880..885]:gene-rna:"c-kit"
(SENT
  (S
    (NP-SBJ-1
      (NP (CD:[730..732] 36) (NNS:[733..738] GISTs))
      (CC:[739..742] and)
      (NP (CD:[743..745] 14) (JJ:[747..752] other)
         (JJ:[753..769] gastrointestinal) (JJ:[770..781] mesenchymal)
         (NNS:[782..788] tumors)))
    (VP (VBD:[789..793] were)
      (VP (VBN:[794..806] investigated)
        (NP-1 (-NONE-:[806..806] *))
        (PP
          (PP (IN:[807..810] for)
            (NP (PRP$:[811..816] their) (NN:[817..827] morphology)
                (CC:[829..832] and) (NN:[833..848] immunophenotype)))
          (CONJP (RB:[849..851] as) (RB:[852..856] well) (IN:[857..859] as))
          (PP (IN:[860..863] for)
            (NP
              (NP (DT:[864..867] the) (NN:[868..876] presence))
              (PP (IN:[877..879] of)
                (NP (NN:[880..885] c-kit) (NNS:[886..895] mutations))))))))
    (.:[895..896] .)))

;sentence 8 Span:897..962
;DNA was  extracted from formalin-fixed, paraffin-embedded tissue.
(SENT
  (S
    (NP-SBJ-1 (NN:[897..900] DNA))
    (VP (VBD:[901..904] was)
      (VP (VBN:[906..915] extracted)
        (NP-1 (-NONE-:[915..915] *))
        (PP (IN:[916..920] from)
          (NP
            (ADJP (NN:[921..929] formalin) (HYPH:[929..930] -)
                  (VBN:[930..935] fixed))
            (,:[935..936] ,)
            (ADJP (NN:[937..945] paraffin) (HYPH:[945..946] -)
                  (VBN:[946..954] embedded))
            (NN:[955..961] tissue)))))
    (.:[961..962] .)))

;sentence 9 Span:963..1019
;Exons 9, 11, 13, and 17  of c-kit were analyzed by SSCP.
;[963..970]:variation-location:"Exons 9"
;[963..968]...[984..986]:variation-location:"Exons"..."17"
;[963..968]...[976..978]:variation-location:"Exons"..."13"
;[963..968]...[972..974]:variation-location:"Exons"..."11"
;[991..996]:gene-rna:"c-kit"
(SENT
  (S
    (NP-SBJ-2
      (NP
        (NP
          (NML-1 (NNS:[963..968] Exons))
          (CD:[969..970] 9))
        (,:[970..971] ,)
        (NP
          (NML-1 (-NONE-:[971..971] *P*))
          (CD:[972..974] 11))
        (,:[974..975] ,)
        (NP
          (NML-1 (-NONE-:[975..975] *P*))
          (CD:[976..978] 13))
        (,:[978..979] ,) (CC:[980..983] and)
        (NP
          (NML-1 (-NONE-:[983..983] *P*))
          (CD:[984..986] 17)))
      (PP (IN:[988..990] of)
        (NP (NN:[991..996] c-kit))))
    (VP (VBD:[997..1001] were)
      (VP (VBN:[1002..1010] analyzed)
        (NP-2 (-NONE-:[1010..1010] *))
        (PP-MNR (IN:[1011..1013] by)
          (NP (NN:[1014..1018] SSCP)))))
    (.:[1018..1019] .)))

;sentence 10 Span:1020..1090
;Bands with altered mobility were excised,  reamplified, and sequenced.
(SENT
  (S
    (NP-SBJ-1
      (NP (NNS:[1020..1025] Bands))
      (PP (IN:[1026..1030] with)
        (NP (JJ:[1031..1038] altered) (NN:[1039..1047] mobility))))
    (VP (VBD:[1048..1052] were)
      (VP (VBN:[1053..1060] excised) (,:[1060..1061] ,)
          (VBN:[1063..1074] reamplified) (,:[1074..1075] ,)
          (CC:[1076..1079] and) (VBN:[1080..1089] sequenced)
        (NP-1 (-NONE-:[1089..1089] *))))
    (.:[1089..1090] .)))

;sentence 11 Span:1091..1303
;C-kit mutations in Exon 11 encoding the  juxtamembrane domain were identified
;in 19 cases (52.8%), with deletions in 12  cases, insertions in 3 cases (2 of
;these as duplications), and point mutations  in 4 cases.
;[1091..1096]:gene-rna:"C-kit"
;[1097..1106]:variation-event:"mutations"
;[1110..1117]:variation-location:"Exon 11"
;[1175..1188]:malignancy:"cases (52.8%)"
;[1195..1204]:variation-type:"deletions"
;[1212..1217]:malignancy:"cases"
;[1219..1229]:variation-type:"insertions"
;[1235..1240]:malignancy:"cases"
;[1256..1268]:variation-type:"duplications"
;[1275..1290]:variation-type:"point mutations"
;[1297..1302]:malignancy:"cases"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (NN:[1091..1096] C-kit) (NNS:[1097..1106] mutations))
        (PP-LOC (IN:[1107..1109] in)
          (NP (NN:[1110..1114] Exon) (CD:[1115..1117] 11))))
      (VP (VBG:[1118..1126] encoding)
        (NP (DT:[1127..1130] the) (NN:[1132..1145] juxtamembrane)
            (NN:[1146..1152] domain))))
    (VP (VBD:[1153..1157] were)
      (VP (VBN:[1158..1168] identified)
        (NP-1 (-NONE-:[1168..1168] *))
        (PP (IN:[1169..1171] in)
          (NP (CD:[1172..1174] 19)
             (NNS:[1175..1180] cases)
            (PRN (-LRB-:[1181..1182] -LRB-)
              (NP (CD:[1182..1186] 52.8) (NN:[1186..1187] %))
              (-RRB-:[1187..1188] -RRB-))))
        (,:[1188..1189] ,)
        (PP (IN:[1190..1194] with)
          (NP
            (NP
              (NP (NNS:[1195..1204] deletions))
              (PP (IN:[1205..1207] in)
                (NP (CD:[1208..1210] 12) (NNS:[1212..1217] cases))))
            (,:[1217..1218] ,)
            (NP
              (NP (NNS:[1219..1229] insertions))
              (PP (IN:[1230..1232] in)
                (NP (CD:[1233..1234] 3) (NNS:[1235..1240] cases)
                  (PRN (-LRB-:[1241..1242] -LRB-)
                    (NP
                      (NP (CD:[1242..1243] 2))
                      (PP (IN:[1244..1246] of)
                        (NP (DT:[1247..1252] these)))
                      (PP (IN:[1253..1255] as)
                        (NP (NNS:[1256..1268] duplications))))
                    (-RRB-:[1268..1269] -RRB-)))))
            (,:[1269..1270] ,) (CC:[1271..1274] and)
            (NP
              (NP (NN:[1275..1280] point) (NNS:[1281..1290] mutations))
              (PP (IN:[1292..1294] in)
                (NP (CD:[1295..1296] 4) (NNS:[1297..1302] cases))))))))
    (.:[1302..1303] .)))

;sentence 12 Span:1304..1537
;The mutations clustered between Codons 553 and 561, pinpointing the  critical
;region for deregulated Kit receptor activation. In both Exons 9 and 13, 
;single mutations could be identified, whereas no mutations were found in Exon
; 17.
;[1308..1317]:variation-event:"mutations"
;[1328..1354]:variation-location:"between Codons 553 and 561"
;[1405..1417]:gene-protein:"Kit receptor"
;[1438..1445]:variation-location:"Exons 9"
;[1438..1443]...[1450..1452]:variation-location:"Exons"..."13"
;[1455..1471]:variation-event:"single mutations"
;[1528..1536]:variation-location:"Exon  17"
(SENT
  (S
    (NP-SBJ (DT:[1304..1307] The) (NNS:[1308..1317] mutations))
    (VP (VBD:[1318..1327] clustered)
      (PP-LOC (IN:[1328..1335] between)
        (NP
          (NP
            (NML-4 (NNS:[1336..1342] Codons))
            (CD:[1343..1346] 553))
          (CC:[1347..1350] and)
          (NP
            (NML-4 (-NONE-:[1350..1350] *P*))
            (CD:[1351..1354] 561))))
      (,:[1354..1355] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1355..1355] *))
        (VP (VBG:[1356..1367] pinpointing)
          (NP
            (NP (DT:[1368..1371] the) (JJ:[1373..1381] critical)
                (NN:[1382..1388] region))
            (PP (IN:[1389..1392] for)
              (NP (JJ:[1393..1404] deregulated)
                (NML (NN:[1405..1408] Kit) (NN:[1409..1417] receptor))
                (NN:[1418..1428] activation)))))))
    (.:[1428..1429] .))
  (S
    (PP-LOC (IN:[1430..1432] In)
      (NP (DT:[1433..1437] both)
        (NP
          (NML-3 (NNS:[1438..1443] Exons))
          (CD:[1444..1445] 9))
        (CC:[1446..1449] and)
        (NP
          (NML-3 (-NONE-:[1449..1449] *P*))
          (CD:[1450..1452] 13))))
    (,:[1452..1453] ,)
    (NP-SBJ-2 (JJ:[1455..1461] single) (NNS:[1462..1471] mutations))
    (VP (MD:[1472..1477] could)
      (VP (VB:[1478..1480] be)
        (VP (VBN:[1481..1491] identified)
          (NP-2 (-NONE-:[1491..1491] *))
          (,:[1491..1492] ,)
          (SBAR-ADV (IN:[1493..1500] whereas)
            (S
              (NP-SBJ-1 (DT:[1501..1503] no) (NNS:[1504..1513] mutations))
              (VP (VBD:[1514..1518] were)
                (VP (VBN:[1519..1524] found)
                  (NP-1 (-NONE-:[1524..1524] *))
                  (PP-LOC (IN:[1525..1527] in)
                    (NP (NN:[1528..1532] Exon) (CD:[1534..1536] 17))))))))))
    (.:[1536..1537] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[1304..1537]::S:S:

;sentence 13 Span:1538..1684
;There were c-kit mutations in 66.6% of benign GISTs (14/21), 83.3% of the 
;malignant (5/6), and 40% of the cases of intermediate malignancy (2/5).
;[1549..1554]:gene-rna:"c-kit"
;[1568..1597]:malignancy:"66.6% of benign GISTs (14/21)"
;[1599..1628]:malignancy:"83.3% of the  malignant (5/6)"
;[1634..1683]:malignancy:"40% of the cases of intermediate malignancy (2/5)"
(SENT
  (S
    (NP-SBJ (EX:[1538..1543] There))
    (VP (VBD:[1544..1548] were)
      (NP-PRD (NN:[1549..1554] c-kit) (NNS:[1555..1564] mutations))
      (PP-LOC (IN:[1565..1567] in)
        (NP
          (NP
            (NP (CD:[1568..1572] 66.6) (NN:[1572..1573] %))
            (PP (IN:[1574..1576] of)
              (NP (JJ:[1577..1583] benign) (NNS:[1584..1589] GISTs)))
            (PRN (-LRB-:[1590..1591] -LRB-)
              (NP
                (NP (CD:[1591..1593] 14))
                (PP (SYM:[1593..1594] /)
                  (NP (CD:[1594..1596] 21))))
              (-RRB-:[1596..1597] -RRB-)))
          (,:[1597..1598] ,)
          (NP
            (NP (CD:[1599..1603] 83.3) (NN:[1603..1604] %))
            (PP (IN:[1605..1607] of)
              (NP (DT:[1608..1611] the) (JJ:[1613..1622] malignant)))
            (PRN (-LRB-:[1623..1624] -LRB-)
              (NP
                (NP (CD:[1624..1625] 5))
                (PP (SYM:[1625..1626] /)
                  (NP (CD:[1626..1627] 6))))
              (-RRB-:[1627..1628] -RRB-)))
          (,:[1628..1629] ,) (CC:[1630..1633] and)
          (NP
            (NP (CD:[1634..1636] 40) (NN:[1636..1637] %))
            (PP (IN:[1638..1640] of)
              (NP
                (NP (DT:[1641..1644] the) (NNS:[1645..1650] cases))
                (PP (IN:[1651..1653] of)
                  (NP (JJ:[1654..1666] intermediate)
                      (NN:[1667..1677] malignancy)))))
            (PRN (-LRB-:[1678..1679] -LRB-)
              (NP
                (NP (CD:[1679..1680] 2))
                (PP (SYM:[1680..1681] /)
                  (NP (CD:[1681..1682] 5))))
              (-RRB-:[1682..1683] -RRB-))))))
    (.:[1683..1684] .)))

;sentence 14 Span:1685..1813
;A low  frequency of mutations in benign GISTs, as reported previously by
;other  researchers, could not be observed in our panel.
;[1718..1730]:malignancy:"benign GISTs"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1685..1686] A) (JJ:[1687..1690] low) (NN:[1692..1701] frequency))
      (PP (IN:[1702..1704] of)
        (NP
          (NP (NNS:[1705..1714] mutations))
          (PP-LOC (IN:[1715..1717] in)
            (NP (JJ:[1718..1724] benign) (NNS:[1725..1730] GISTs))))))
    (,:[1730..1731] ,)
    (SBAR-ADV (IN:[1732..1734] as)
      (S
        (NP-SBJ-1 (-NONE-:[1734..1734] *))
        (VP (VBN:[1735..1743] reported)
          (NP-1 (-NONE-:[1743..1743] *))
          (ADVP-TMP (RB:[1744..1754] previously))
          (PP (IN:[1755..1757] by)
            (NP-LGS (JJ:[1758..1763] other) (NNS:[1765..1776] researchers))))))
    (,:[1776..1777] ,)
    (VP (MD:[1778..1783] could) (RB:[1784..1787] not)
      (VP (VB:[1788..1790] be)
        (VP (VBN:[1791..1799] observed)
          (NP-2 (-NONE-:[1799..1799] *))
          (PP (IN:[1800..1802] in)
            (NP (PRP$:[1803..1806] our) (NN:[1807..1812] panel))))))
    (.:[1812..1813] .)))

;sentence 15 Span:1814..1983
;Interestingly, all GISTs with  c-kit mutations displayed a spindle cell
;phenotype, whereas mutations were  absent in all 7 tumors with an epithelioid
;component (P =.03).
;[1833..1838]:malignancy:"GISTs"
;[1845..1850]:gene-rna:"c-kit"
;[1937..1943]:malignancy:"tumors"
(SENT
  (S
    (ADVP (RB:[1814..1827] Interestingly))
    (,:[1827..1828] ,)
    (NP-SBJ
      (NP (DT:[1829..1832] all) (NNS:[1833..1838] GISTs))
      (PP (IN:[1839..1843] with)
        (NP (NN:[1845..1850] c-kit) (NNS:[1851..1860] mutations))))
    (VP (VBD:[1861..1870] displayed)
      (NP (DT:[1871..1872] a)
        (NML (NN:[1873..1880] spindle) (NN:[1881..1885] cell))
        (NN:[1886..1895] phenotype))
      (,:[1895..1896] ,)
      (SBAR-ADV (IN:[1897..1904] whereas)
        (S
          (NP-SBJ (NNS:[1905..1914] mutations))
          (VP (VBD:[1915..1919] were)
            (ADJP-PRD (JJ:[1921..1927] absent))
            (PP-LOC (IN:[1928..1930] in)
              (NP
                (NP (DT:[1931..1934] all) (CD:[1935..1936] 7)
                    (NNS:[1937..1943] tumors))
                (PP (IN:[1944..1948] with)
                  (NP (DT:[1949..1951] an) (JJ:[1952..1963] epithelioid)
                      (NN:[1964..1973] component)))
                (PRN (-LRB-:[1974..1975] -LRB-)
                  (S
                    (NP-SBJ (NN:[1975..1976] P))
                    (VP (SYM:[1977..1978] =)
                      (NP (CD:[1978..1981] .03))))
                  (-RRB-:[1981..1982] -RRB-))))))))
    (.:[1982..1983] .)))

;section 16 Span:1984..2080
;This finding  suggests a relationship between c-kit mutation and histological
;subtype in  GISTs.
;[2030..2035]:gene-rna:"c-kit"
;[2074..2079]:malignancy:"GISTs"
(SEC
  (S
    (NP-SBJ (DT:[1984..1988] This) (NN:[1989..1996] finding))
    (VP (VBZ:[1998..2006] suggests)
      (NP
        (NP (DT:[2007..2008] a) (NN:[2009..2021] relationship))
        (PP (IN:[2022..2029] between)
          (NP
            (NP (NN:[2030..2035] c-kit) (NN:[2036..2044] mutation))
            (CC:[2045..2048] and)
            (NP (JJ:[2049..2061] histological) (NN:[2062..2069] subtype))))
        (PP-LOC (IN:[2070..2072] in)
          (NP (NNS:[2074..2079] GISTs)))))
    (.:[2079..2080] .)))
;ERROR_Entity in section[2030..2035]:gene-rna "c-kit"
;ERROR_Entity in section[2074..2079]:malignancy "GISTs"

;section 17 Span:2084..2129
;PMID: 11850541 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2084..2088] PMID) (::[2088..2089] :) (CD:[2090..2098] 11850541)
        (NN:[2099..2100] -LSB-) (NNP:[2100..2106] PubMed) (::[2107..2108] -)
        (NN:[2109..2116] indexed) (IN:[2117..2120] for)
        (NNP:[2121..2129] MEDLINE-RSB-)))
